Pulmonx Corporation (Nasdaq: LUNG) reported third-quarter 2026 revenue of $22.8 million, up 6% from $21.5 million a year earlier. The company posted a GAAP net loss of $8.4 million, or $0.19 per share, compared with a $14.0 million loss, or $0.34 per share, in the prior-year quarter.
U.S. revenue rose 7% to $14.9 million, while international revenue increased 5% to $7.9 million. Pulmonx maintained its full-year 2026 revenue outlook of $90 million to $92 million.
- Third-quarter gross profit was $17.4 million, with gross margin of 76%.
- Operating expenses declined 18% to $24.9 million.
- Cash and cash equivalents totaled $52.7 million as of September 30, 2026.
- International revenue excluding China increased 9% year over year on a GAAP basis.
- Full-year 2026 operating expense guidance is $108 million to $109 million.
$LUNG Insider Trading Activity
$LUNG insiders have traded $LUNG stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:
- GLENDON E. III FRENCH (President and CEO) has made 0 purchases and 2 sales selling 41,882 shares for an estimated $94,653.
- DAVID AARON LEHMAN (General Counsel) has made 0 purchases and 8 sales selling 28,928 shares for an estimated $54,869.
- SRIKANTH RADHAKRISHNAN (Chief Science & Techn. Officer) has made 0 purchases and 8 sales selling 28,742 shares for an estimated $54,519.
- GEOFFREY BERAN ROSE (Chief Commercial Officer) has made 0 purchases and 8 sales selling 15,902 shares for an estimated $30,161.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LUNG Hedge Fund Activity
We have seen 47 institutional investors add shares of $LUNG stock to their portfolio, and 61 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,779,117 shares (-66.8%) from their portfolio in Q2 2026, for an estimated $2,312,852
- BANK OF AMERICA CORP /DE/ removed 1,166,826 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,516,873
- MORGAN STANLEY removed 1,070,641 shares (-26.8%) from their portfolio in Q2 2026, for an estimated $1,391,833
- ALMITAS CAPITAL LLC added 1,064,202 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,383,462
- DEUTSCHE BANK AG\ removed 761,362 shares (-65.4%) from their portfolio in Q2 2026, for an estimated $989,770
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 720,279 shares (-37.1%) from their portfolio in Q2 2026, for an estimated $936,362
- BARCLAYS PLC removed 649,297 shares (-95.0%) from their portfolio in Q2 2026, for an estimated $844,086
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
